3D Cell Culture Market Outline New Developments with Operational Updates in Industry Forecast 2026

3D cell culture is group of biological cells that are allowed to grow in artificial media in all three dimensions. It is used in drug discovery and tissue engineering, owing to their property of providing predictive data for in vivo tests and physiologically relevant information. 3D cell cultures have more stability and longer lifespan as compared to 2D cell culture system, which makes them suitable for long term studies long term effects of the drug on cells. 3D cell culture systems are mostly grown in bioreactors or 3D cell colonies. Studies have reported that they function similar to natural cells due to which they have applications in cancer research.

Request Sample Copy of Research Report: https://bit.ly/2HaEhCX

Increasing adoption of 3D cell culture by cancer research organizations is expected to drive growth of 3D cell culture market:

High prevalence of various types of cancers and the need for affordable and effective treatment are the major factor driving growth of the 3D cell culture system market. For instance, according to the data published by World Health Organization (WHO), cancer accounted for 8.8 million of deaths worldwide in 2015. Increasing investment in healthcare, development of optimized 3D assays, R&D, and other research related activities are also fuelling growth of 3D cell culture market. The 3D cultures is majorly used for testing efficiency of new drug molecule, which can be used for treatment of chronic diseases. This increases adoption of 3D cell culture by pharmaceuticals and biotechnology industries, which in turn is driving growth of 3D cell culture market.

Increasing investment by government and private companies in novel drug discovery is expected to drive growth of 3D cell culture market in Asia Pacific:

Regional segmentation of 3D cell culture market by Coherent Market Insights comprises North America, Latin America, Europe, Asia Pacific, Africa, and Middle East. Advances in drug discovery is the major factor driving growth of the market in Asia Pacific region. Increasing government investments in healthcare sector, low operating costs of industries, investments by pharmaceutical and analytical instrumental companies in 3D cell culture projects to meet the demand for cancer treatments and organs development are some other factors fuelling growth of 3D cell culture market in this region.

Major players in market are focused on providing the product according to specific requirements of researchers. For instance, Thermo Fisher scientific has collaborated with Applikon Biotechnology and launched new single use bioreactor controller platforms-i-control and ez-control. Whereas the novel concept of customized 3D cell culture product has helped the small companies to enter in 3D cell culture industry. Major market players are adopting strategies such as agreement and partnership to maintain the leading position in market. For instance, Lonza Group Ltd. has expanded presence in the 3D cell culture market by signing an agreement with TAP Biosystems to distribute the RAFT 3D cell culture systems.

Key players operating the 3D cell culture market includes 3D Biotek, Advanced Biomatrix, Becton and Dickinson Company (BD), corning Incorporated, Global cell solutions Inc., Thermo Fisher scientific Inc., VWR Corporation, Nanofiber solutions, Lonza Group Ltd., Synthecon incorporated, and Tecan Trading AG.

Request For Customization of Research Report @ https://bit.ly/2EA4Rn9

3D Cell Culture Market Taxonomy:

The global 3D cell culture market is segmented on the basis of Product Type And Application
On the basis of Product Type - Scaffold based platforms, Macro-Porous scaffolds, Micro porous scaffolds, Nano porous scaffolds, Scaffold free platforms, Solid scaffolds, Bioreactors, Gels, Microchips, Services
On the basis of Application - Drug Discovery, Stem cell research, Cancer research, Regenerative medicine

Also, Coherent Market Insights has a proprietary database of pipeline biologics and biosimilars, called PHASE-XS. This database provides analytical data in addition to the clinical information of ongoing trials for biologics and biosimilars. An amalgamation of more than 30 parameters, PHASE-XS helps biotechnology and pharmaceutical companies to analyze the market trend, competition, and market potential. For more information or to access this database, kindly click on the below link or contact at sales@coherentmarketinsights.com
https://www.coherentmarketinsights.com/phase-xs/

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:

Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

This release was published on openPR.